VeriSeq PGS

The VeriSeq PGS Kit takes advantage of next-generation sequencing (NGS) technology to provide comprehensive, accurate screening of all 24 chromosomes for selection of euploid embryos. Preimplantation genetic screening (PGS) results generated using VeriSeq PGS are comparable to those achieved with the widely used array-based 24sure technology. In addition, NGS offers the opportunity for improved assay workflow, higher throughput, and enhanced performance.

Ultra-Low Input
NGS offers a highly sensitive method for screening embryos, requiring as little as 1 ng of DNA from a SurePlex DNA amplification reaction. DNA can be obtained from a blastomere biopsy from a day 3 embryo or from a trophectodermal (TE) biopsy from a blastocyst.

  • Industry-leading data quality: 90% of the world’s sequencing data are generated using Illumina sequencing by synthesis (SBS) technology
  • Fast, streamlined workflow: Sample to answer in approximately 12 hours
  • High-throughput analysis: Screen up to 24 samples per run

Complete Solution
The VeriSeq PGS Kit includes everything needed for PGS using Illumina NGS technology in a single kit:

  • SurePlex DNA Amplification System for amplifying DNA from an embryo biopsy
  • VeriSeq Library Preparation Kit-PGS for preparing samples for sequencing
  • VeriSeq Index Kit-PGS for multiplexing samples for a single sequencing run
  • MiSeq Reagent Kit v3-PGS for sequencing prepared samples on the MiSeq System
  • BlueFuse Multi analysis software license for analyzing, storing, and reporting VeriSeq results

For research use only. Not for in vitro diagnostic use.

Product Literature

Description Document Type File Info
VeriSeq PGS Kit - MiSeq System Product Information Sheet Product Information Sheet PDF(< 1 MB)
VeriSeq PGS Solution on the MiSeq System Data Sheet PDF(< 1 MB)
VeriSeq NIPT Analysis Software (16 Samples) Data Sheet PDF(< 1 MB)

Catalog IDs: RH-101-1001